|
End-of-day quote
Thailand S.E.
2026-11-06
|
5-day change | 1st Jan Change | ||
| 4.460 THB | -0.45% |
|
0.00% | -38.06% |
| 10-20 | Healthlead Buys Back Shares | MT |
| 08-17 | Healthlead Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Company Valuation: Healthlead
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Market Cap 1 | 4,923 | 6,691 | 2,829 | 2,774 | 1,886 |
| Change | - | 35.91% | -57.72% | -1.92% | -32.02% |
| Enterprise Value (EV) 1 | 4,332 | 6,205 | 2,495 | 2,554 | 1,655 |
| Change | - | 43.25% | -59.79% | 2.37% | -35.2% |
| P/E | 46.9x | 56.6x | 37.9x | 35.4x | 24.8x |
| PBR | 5.69x | 7.1x | 2.92x | 2.76x | 1.95x |
| PEG | 2.3x | 4.5x | -1x | 7.37x | 31.41x |
| Capitalization / Revenue | 4.05x | 4.35x | 1.7x | 1.38x | 0.83x |
| EV / Revenue | 3.56x | 4.03x | 1.5x | 1.27x | 0.73x |
| EV / EBITDA | 37x | 38.1x | 19.8x | 19.5x | 10.8x |
| EV / EBIT | 42.2x | 41.8x | 24.8x | 26.8x | 15x |
| EV / FCF | 87.9x | -737x | -156x | 830x | 11.7x |
| FCF Yield | 1.14% | -0.14% | -0.64% | 0.12% | 8.55% |
| Dividend per Share 2 | 0.28 | 0.18 | 0.15 | 0.17 | 0.22 |
| Rate of return | 1.55% | 0.73% | 1.44% | 1.67% | 3.06% |
| EPS 2 | 0.3861 | 0.4347 | 0.2746 | 0.2877 | 0.29 |
| Distribution rate | 72.5% | 41.4% | 54.6% | 59.1% | 75.9% |
| Net sales 1 | 1,216 | 1,538 | 1,659 | 2,011 | 2,270 |
| EBITDA 1 | 117.1 | 163 | 126.3 | 131.3 | 153.5 |
| EBIT 1 | 102.6 | 148.4 | 100.7 | 95.39 | 110.6 |
| Net income 1 | 79.66 | 118.2 | 74.68 | 78.26 | 77.86 |
| Net Debt 1 | -591.5 | -486 | -333.6 | -220.1 | -230.9 |
| Reference price 2 | 18.100 | 24.600 | 10.400 | 10.200 | 7.200 |
| Nbr of stocks (in thousands) | 272,000 | 272,000 | 272,000 | 272,000 | 261,956 |
| Announcement Date | 2/25/22 | 2/27/23 | 2/28/24 | 2/28/25 | 2/25/26 |
1THB in Million2THB
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 33.35M | |
| 19.6x | 0.87x | 13.04x | -.--% | 17.58B | |
| 23.06x | 0.4x | 6.15x | 1.96% | 7.07B | |
| 18.01x | 0.81x | 8.46x | 2.08% | 6.88B | |
| 21.69x | 0.82x | 14.23x | 1.15% | 6.48B | |
| 17.07x | 1.07x | 7.54x | 2.59% | 4.85B | |
| 17.08x | 0.76x | 8.69x | 2.49% | 4.69B | |
| 16.44x | 0.69x | 5.4x | 4.55% | 3.54B | |
| 16.35x | 0.47x | 7.79x | 1.29% | 3.32B | |
| 18.32x | 0.39x | 6.07x | 1.26% | 3.28B | |
| Average | 18.62x | 0.70x | 8.59x | 1.93% | 5.77B | |
| Weighted average by Cap. | 19.20x | 0.75x | 9.80x | 1.46% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- HL Stock
- Valuation Healthlead
Select your edition
All financial news and data tailored to specific country editions
